Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ITCI Intra Cellular Therapies Inc

128,04

0,22 (0,17%)

Zuletzt aktualisiert: 20:10:31

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more Intra Cellular Therapies Charts.

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more Intra Cellular Therapies Charts.

News Intra Cellular Therapies Inc

Form PREM14A - Preliminary proxy statements relating to merger or acquisition
Mittwoch 5 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 13 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 13 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
Montag 13 Januar 2025 (1 Monat vor) • GlobeNewswire Inc.

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
Montag 13 Januar 2025 (1 Monat vor) • Business Wire

Form 8-K - Current report
Freitag 10 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz
Freitag 10 Januar 2025 (1 Monat vor) • GlobeNewswire Inc.

Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Montag 6 Januar 2025 (1 Monat vor) • GlobeNewswire Inc.

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting
Mittwoch 11 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Intra Cellular Therapies Inc News-Artikel

ARS vs US Dollar

BlackRock Institutional ...

BNP Paribas Issuance

British American Tobacco

Jpmorgan Betabuilders In...

BNP Paribas Issuance

BWP vs Sterling

BNP Paribas Issuance

Bank Fuer Tirol Und Vora...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen